This brand name is authorized in Australia, Germany, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa
The drug CORDARONE contains one active pharmaceutical ingredient (API):
1
Amiodarone
UNII 976728SY6Z - AMIODARONE HYDROCHLORIDE
|
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
CORDARONE X Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CORDARONE X 100 Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
C01BD01 | Amiodarone | C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BD Antiarrhythmics, class III |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2343H, 2344J |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 01408051, 02156723, 02235693, 02235701, 02235718, 16582211, 16582234, 16582240 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 23.175-1-04-07 |
Country: EE | Ravimiamet | Identifier(s): 1016233, 1016244, 1730753 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 142307, 421180 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60662396, 62305927, 64408662, 68973926 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 13396, 13423, 209123 |
Country: HK | Department of Health Drug Office | Identifier(s): 27294, 27296 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-204962082, HR-H-451337551 |
Country: IT | Agenzia del Farmaco | Identifier(s): 025035015 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1000504, 1016571, 1088663, 1092754 |
Country: MT | Medicines Authority | Identifier(s): MA1359/01401, MA1359/01402 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 148M81, 276M81 |
Country: NL | Z-Index G-Standaard | Identifier(s): 15731839 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 25119 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 3467, 3468, 3469 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100015820, 100015850, 100272557, 100274119, 100326862, 100330881, 100334206, 100338322, 100339824, 100344506, 100346586, 100346764, 100377894, 100385741, 100413800, 100429697, 100456045 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W64483001, W64483002 |
Country: SG | Health Sciences Authority | Identifier(s): 00852P, 09784P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6260032, 9263071 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699809018020, 8699809759107 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): P/6.2/165, S/6.2/384 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.